'Microprotein' biotech Velia, backed by TCG and Foresite, to wind down
San Diego-based Velia Therapeutics, which was working on so-called microproteins, is in the process of winding down about two years after a $55 million Series …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
